Collaborative R&D as a Solutions Partner
First written in FY2017. 20 of 24 entries say "Restated". Latest entry: FY2026.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「R&D expenditure for the fiscal year was ¥672 million."The field test of the AI system “Prome Teacher” has been completed.""Going forward, the company plans to strongly promote remote monitoring and operational support using AI and IoT, as well as the development of digital twins, based on this platform."」
Collaborative R&D reached ¥672 million, progressing through completion of the field test for the AI system to an equipment ledger application and plans for remote monitoring, operational support and digital twins. - FY2024-Q3RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the third quarter was ¥448 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the third quarter.」
The company reconfirmed that there were no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions. R&D expenditure was ¥448 million. - FY2024-Q2RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the second quarter was ¥307 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the second quarter.」
The company reported no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions, and reported R&D expenditure of ¥307 million for the consolidated cumulative period through the second quarter. - FY2024-Q1RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the first quarter was ¥148 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the first quarter.」
The company reported no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions, and reported first-quarter R&D expenditure of ¥148 million. - FY2023AdvancedAnnual report
「As a solution partner, our group promotes R&D and product development to meet customer expectations, with the R&D division playing a central role and working in cooperation with related divisions. R&D expenditure for the fiscal year was ¥576 million.」
Collaborative R&D expanded to ¥576 million, progressing to concrete development projects including hydrogen-fuel burners, next-generation mixers and a DX system for factory management. - FY2023-Q3RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the third quarter was ¥423 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the third quarter.」
The company reported no material changes in the status of its R&D activities and reported R&D expenditure of ¥423 million for the cumulative period through the third quarter. - FY2023-Q2RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the second quarter was ¥276 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the second quarter.」
The company reported no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions, and reported R&D expenditure of ¥276 million for the consolidated cumulative period through the second quarter. - FY2022-Q3RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the third quarter was ¥335 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the third quarter.」
While reporting no material changes in its collaborative R&D activities, the company reported R&D expenditure of ¥335 million for the cumulative period through the third quarter. - FY2022-Q2RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the second quarter was ¥220 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the second quarter.」
The company reported no material changes in its collaborative R&D activities and reported R&D expenditure of ¥220 million for the consolidated cumulative period through the second quarter. - FY2022-Q1RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the first quarter was ¥109 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the first quarter.」
The company reported no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions, and reported first-quarter R&D expenditure of ¥109 million. - FY2021AdvancedAnnual report
「As a solution partner, our group promotes R&D and product development to meet customer expectations, with the R&D division playing a central role and working in cooperation with related divisions. R&D expenditure for the fiscal year was ¥392 million.」
R&D expenditure was ¥392 million, with the results of collaborative R&D taking concrete form through the completion of development of carbonized-fuel burners and the commercialization and delivery of CBD120 and ONZE-MIX products. - FY2021-Q3RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the third quarter was ¥270 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the third quarter.」
The company reported no material changes in the status of its R&D activities and reported R&D expenditure of ¥270 million for the consolidated cumulative period through the third quarter. - FY2021-Q2RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the second quarter was ¥171 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the second quarter.」
The company reported no material changes in its established R&D activities, centered on the R&D division and conducted in cooperation with related divisions, and reported R&D expenditure of ¥171 million. - FY2020-Q3RestatedAnnual report
「R&D expenditure for the group's consolidated cumulative period through the third quarter was ¥289 million. There were no material changes in the status of the group's R&D activities during the consolidated cumulative period through the third quarter.」
The company maintained its policy that there were no material changes in its R&D activities and reported R&D expenditure of ¥289 million for the cumulative period through the third quarter. - FY2020-Q2RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative second quarter was ¥204 million. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter.」
The company maintained its policy that there were no material changes in research and development activities and reported research and development expenses of ¥204 million for the cumulative second quarter. - FY2020-Q1RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative first quarter was ¥101 million. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter.」
The company maintained its policy that there were no material changes in research and development activities and reported research and development expenses of ¥101 million for the cumulative first quarter. - FY2019RestatedAnnual report
「As a solutions partner, the Group promotes research and development and product development that meet customer expectations, led by the research and development division in cooperation and collaboration with related divisions.」
The company maintained its approach of coordinating with related divisions, led by the research and development division, and research and development expenses for the current consolidated fiscal year were ¥211 million. - FY2019-Q3RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative third quarter was ¥211 million. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter.」
The company maintained its policy that there were no material changes in research and development activities and reported research and development expenses of ¥211 million for the cumulative third quarter. - FY2019-Q2RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative second quarter was ¥145 million. There were no material changes in the status of the Group’s research and development activities during the cumulative second quarter.」
The company maintained its previous policy that there were no material changes in research and development activities and reported research and development expenses of ¥145 million for the cumulative second quarter. - FY2019-Q1RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative first quarter was ¥71 million. There were no material changes in the status of the Group’s research and development activities during the cumulative first quarter.」
The company maintained its policy that there were no material changes in research and development activities and reported research and development expenses of ¥71 million for the cumulative first quarter. - FY2018-Q3RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative third quarter was ¥221 million. There were no material changes in the status of the Group’s research and development activities during the cumulative third quarter.」
The company maintained its previous policy that there were no material changes in research and development activities and reported research and development expenses of ¥221 million for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative second quarter was ¥145 million.」
While stating that there were no material changes in research and development activities, the company reported research and development expenses of ¥145 million for the cumulative second quarter. - FY2018-Q1RestatedAnnual report
「The Group’s total research and development expenditure for the cumulative first quarter was ¥75 million.」
The company stated that there were no material changes in research and development activities and reported research and development expenses of ¥75 million for the first quarter. - FY2017First statedAnnual report
「As a solutions partner, the Group promotes research and development and product development that meet customer expectations, led by the research and development division in cooperation and collaboration with related divisions.」
The company describes an approach to research and development in which the research and development division serves as the core and collaborates with related divisions, with the aim of becoming a solutions partner that meets customer expectations.